Edward Bowman
16Patents
6h-index
41Co-inventors
66Inventor score
Filing activity: Jul 2, 2001 → Oct 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7332156B2 | Methods of treating wounds using IL-23 | Chemistry; Metallurgy | 26 | Expired |
| US10323090B2 | PD1 and/or LAG3 binders | Chemistry; Metallurgy | 22 | Active |
| US10544222B2 | PD1/CTLA4 binders | Emerging Cross-Sectional Technologies | 20 | Active |
| US7575741B2 | Methods of treating cutaneous ulcers and grafts using IL-23 | Chemistry; Metallurgy | 19 | Active |
| US7846443B2 | Antibodies to IL-17A | Chemistry; Metallurgy | 15 | Active |
| US7893215B2 | Agonist antibodies to IL-23 receptor | Chemistry; Metallurgy | 15 | Active |
| US8753843B2 | Antibodies to IL-17A | Chemistry; Metallurgy | 2 | Active |
| US6824781B2 | Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist | Human Necessities | 2 | Expired |
| US8062634B2 | Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor | Chemistry; Metallurgy | 2 | Active |
| US11155619B2 | PD1 and/or LAG3 binders | Chemistry; Metallurgy | 2 | Active |
| US8193319B2 | Antibodies to IL-17A | Chemistry; Metallurgy | 1 | Active |
| US11168136B2 | PD1 and/or LAG3 binders | Chemistry; Metallurgy | 1 | Active |
| US11168135B2 | PD1 and/or LAG3 binders | Chemistry; Metallurgy | 1 | Active |
| US12351630B2 | PD1 and/or LAG3 binders | Chemistry; Metallurgy | 0 | Active |
| US11827684B2 | Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer | Human Necessities | 0 | Active |
| US12358986B2 | Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.